September 2022

Dapagliflozin consistently reduced the risk of CV death or HHF, HHF alone, and progression of kidney disease regardless of background use of CV medications, investigators say.

Nearly half of the study cohort did not fill a statin prescription within 90 days after an ASCVD event.

Timing, urgency, and risk category of surgery were not associated with increased risk of the primary end point.

Preventable factors including obesity, hypertension, and physical activity are disparately impacting the rate of dementia among people of color.

New findings suggest low-dose rivaroxaban plus aspirin was associated with lower VTE risk compared with aspirin alone.